These results suggest that CD8+ T cells mediate the anti-tumorigenic response induced by RANK loss in tumor cells, and that the exacerbated T-cell response in RANK−/− tumors is responsible for the delay in tumor formation. The gene discussed is TNFRSF11A; the disease is neoplasm.